Literature DB >> 22754041

Altered sleep and affect in the neurotensin receptor 1 knockout mouse.

Karrie Fitzpatrick1, Christopher J Winrow, Anthony L Gotter, Joshua Millstein, Janna Arbuzova, Joseph Brunner, Andrew Kasarskis, Martha H Vitaterna, John J Renger, Fred W Turek.   

Abstract

STUDY
OBJECTIVE: Sleep and mood disorders have long been understood to have strong genetic components, and there is considerable comorbidity of sleep abnormalities and mood disorders, suggesting the involvement of common genetic pathways. Here, we examine a candidate gene implicated in the regulation of both sleep and affective behavior using a knockout mouse model.
DESIGN: Previously, we identified a quantitative trait locus (QTL) for REM sleep amount, REM sleep bout number, and wake amount in a genetically segregating population of mice. Here, we show that traits mapping to this QTL correlated with an expression QTL for neurotensin receptor 1 (Ntsr1), a receptor for neurotensin, a ligand known to be involved in several psychiatric disorders. We examined sleep as well as behaviors indicative of anxiety and depression in the NTSR1 knockout mouse. MEASUREMENTS AND
RESULTS: NTSR1 knockouts had a lower percentage of sleep time spent in REM sleep in the dark phase and a larger diurnal variation in REM sleep duration than wild types under baseline conditions. Following sleep deprivation, NTSR1 knockouts exhibited more wake and less NREM rebound sleep. NTSR1 knockouts also showed increased anxious and despair behaviors.
CONCLUSIONS: Here we illustrate a link between expression of the Ntsr1 gene and sleep traits previously associated with a particular QTL. We also demonstrate a relationship between Ntsr1 and anxiety and despair behaviors. Given the considerable evidence that anxiety and depression are closely linked with abnormalities in sleep, the data presented here provide further evidence that neurotensin and Ntsr1 may be a component of a pathway involved in both sleep and mood disorders.

Entities:  

Keywords:  NTSR1; Sleep; anxiety; depression; neurotensin

Mesh:

Substances:

Year:  2012        PMID: 22754041      PMCID: PMC3369230          DOI: 10.5665/sleep.1958

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  34 in total

1.  Neurotensin-induced bursting of cholinergic basal forebrain neurons promotes gamma and theta cortical activity together with waking and paradoxical sleep.

Authors:  E G Cape; I D Manns; A Alonso; A Beaudet; B E Jones
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

2.  Antidepressant-like effect of neurotensin administered in the ventral tegmental area in the forced swimming test.

Authors:  L Cervo; C Rossi; E Tatarczynska; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Dynamic aspects of sleep disturbance in relation to mental illness.

Authors:  F Snyder
Journal:  Biol Psychiatry       Date:  1969-04       Impact factor: 13.382

4.  Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression.

Authors:  D J Kupfer; F G Foster
Journal:  Lancet       Date:  1972-09-30       Impact factor: 79.321

5.  Identification of causal genes, networks, and transcriptional regulators of REM sleep and wake.

Authors:  Joshua Millstein; Christopher J Winrow; Andrew Kasarskis; Joseph R Owens; Lili Zhou; Keith C Summa; Karrie Fitzpatrick; Bin Zhang; Martha H Vitaterna; Eric E Schadt; John J Renger; Fred W Turek
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

6.  Which depressive symptoms are related to which sleep electroencephalographic variables?

Authors:  M L Perlis; D E Giles; D J Buysse; M E Thase; X Tu; D J Kupfer
Journal:  Biol Psychiatry       Date:  1997-11-15       Impact factor: 13.382

7.  [Plasma neuropeptides in affective and anxiety disorders].

Authors:  J Saiz Ruiz; J L Carrasco Perera; A Hernanz
Journal:  Arch Neurobiol (Madr)       Date:  1992 Jan-Feb

8.  Sleep and psychiatric disorders. A meta-analysis.

Authors:  R M Benca; W H Obermeyer; R A Thisted; J C Gillin
Journal:  Arch Gen Psychiatry       Date:  1992-08

9.  Comorbidity of mental and insomnia disorders in the general population.

Authors:  M M Ohayon; M Caulet; P Lemoine
Journal:  Compr Psychiatry       Date:  1998 Jul-Aug       Impact factor: 3.735

10.  Effects of neurotensin on EEG and event-related potentials in the rat.

Authors:  P Robledo; W M Kaneko; C L Ehlers
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

View more
  15 in total

1.  Rare variants in neuronal excitability genes influence risk for bipolar disorder.

Authors:  Seth A Ament; Szabolcs Szelinger; Gustavo Glusman; Justin Ashworth; Liping Hou; Nirmala Akula; Tatyana Shekhtman; Judith A Badner; Mary E Brunkow; Denise E Mauldin; Anna-Barbara Stittrich; Katherine Rouleau; Sevilla D Detera-Wadleigh; John I Nurnberger; Howard J Edenberg; Elliot S Gershon; Nicholas Schork; Nathan D Price; Richard Gelinas; Leroy Hood; David Craig; Francis J McMahon; John R Kelsoe; Jared C Roach
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

2.  Common variants in DRD2 are associated with sleep duration: the CARe consortium.

Authors:  Brian E Cade; Daniel J Gottlieb; Diane S Lauderdale; David A Bennett; Aron S Buchman; Sarah G Buxbaum; Philip L De Jager; Daniel S Evans; Tibor Fülöp; Sina A Gharib; W Craig Johnson; Hyun Kim; Emma K Larkin; Seung Ku Lee; Andrew S Lim; Naresh M Punjabi; Chol Shin; Katie L Stone; Gregory J Tranah; Jia Weng; Kristine Yaffe; Phyllis C Zee; Sanjay R Patel; Xiaofeng Zhu; Susan Redline; Richa Saxena
Journal:  Hum Mol Genet       Date:  2015-10-13       Impact factor: 6.150

Review 3.  Role of central neurotensin in regulating feeding: Implications for the development and treatment of body weight disorders.

Authors:  Laura E Schroeder; Gina M Leinninger
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-12-27       Impact factor: 5.187

4. 

Authors:  Laura E Schroeder; Ryan Furdock; Cristina Rivera Quiles; Gizem Kurt; Patricia Perez-Bonilla; Angela Garcia; Crystal Colon-Ortiz; Juliette Brown; Raluca Bugescu; Gina M Leinninger
Journal:  Neuropeptides       Date:  2019-05-06       Impact factor: 3.286

Review 5.  Animal models of sleep disorders.

Authors:  Linda A Toth; Pavan Bhargava
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

6.  Manipulations of Central Amygdala Neurotensin Neurons Alter the Consumption of Ethanol and Sweet Fluids in Mice.

Authors:  María Luisa Torruella-Suárez; Jessica R Vandenberg; Elizabeth S Cogan; Gregory J Tipton; Adonay Teklezghi; Kedar Dange; Gunjan K Patel; Jenna A McHenry; J Andrew Hardaway; Pranish A Kantak; Nicole A Crowley; Jeffrey F DiBerto; Sara P Faccidomo; Clyde W Hodge; Garret D Stuber; Zoé A McElligott
Journal:  J Neurosci       Date:  2019-11-19       Impact factor: 6.167

7.  Lateral Hypothalamic Neurotensin Neurons Orchestrate Dual Weight Loss Behaviors via Distinct Mechanisms.

Authors:  Hillary L Woodworth; Bethany G Beekly; Hannah M Batchelor; Raluca Bugescu; Patricia Perez-Bonilla; Laura E Schroeder; Gina M Leinninger
Journal:  Cell Rep       Date:  2017-12-12       Impact factor: 9.423

8.  Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in rats.

Authors:  Adam J Prus; Todd M Hillhouse; Amber L LaCrosse
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-11-23       Impact factor: 5.067

Review 9.  Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders.

Authors:  Chelsea A Vadnie; Jun Hyun Park; Noha Abdel Gawad; Ada Man Choi Ho; David J Hinton; Doo-Sup Choi
Journal:  Front Neurosci       Date:  2014-09-18       Impact factor: 4.677

10.  Computationally efficient permutation-based confidence interval estimation for tail-area FDR.

Authors:  Joshua Millstein; Dmitri Volfson
Journal:  Front Genet       Date:  2013-09-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.